Is Blue Lotus (Nymphaea caerulea) Legal in Delaware? (2026)

Instrument

statute

Source

https://delcode.delaware.gov/title16/c047/sc02/index.html

Retrieved

2026-06-19

Fingerprint

68691bb2616a99d4

**§ 4714(d)** "Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: … (4) Bufotenine; (5) Diethyltryptamine; (6) Dimethyltryptamine; … (14) Psilocybin; (15) Psilocyn; … (23) Alpha-ethyltrytamine [sic]."
— 16 Del. C. § 4714(d), official Delaware Code Online: https://delcode.delaware.gov/title16/c047/sc02/index.html (4-HO-MET not named; no tryptamine structural class)

Instrument

Uniform Controlled Substances Act - Definitions (Controlled substance; Designer drug)

Source

https://delcode.delaware.gov/title16/c047/sc01/index.html

Retrieved

2026-07-20

Fingerprint

05e12a90636e64b4

(7) Controlled substance means a drug, substance or immediate precursor in Schedules I through V of subchapter II of this chapter. For purposes of the crimes set forth in subchapters IV and V of this chapter, and of forfeiture set forth in Section 4784 of this title, controlled substance includes designer drug, as defined in paragraph (10) of this section. (10) Designer drug means a substance that has a chemical structure substantially similar to that of a controlled substance or that was specifically designed to or may produce an effect substantially similar to that of a controlled substance. Examples of chemical classes in which designer drugs are found include, but are not limited to, the following: Phenethylamines, N-substituted piperidines, morphinans, ecgonines, quinazolinones, substituted indoles, arylcycloalkylamines, cannabinoids, cathinones, and any synthetic analogue of a controlled substance. Designer drug does not include any substance that was manufactured, delivered or dispensed in conformance with an approved new drug application, or an exemption for investigating use within the meaning of Section 505 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. Section 355), or that was manufactured, delivered or dispensed in conformance with a registration issued by the Attorney General of the United States within the meaning of Sections 301-304 of the Federal Controlled Substances Act (21 U.S.C. Sections 821-824).